13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $45.7M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

ANL Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Adlai Nortye Ltd. (ANL), a Healthcare sector company. ANL is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $45.7m in revenue. Based on the latest XBRL financial filings (FY 2023), Adlai Nortye Ltd. reports quarterly revenue of $5.0M, net income of $-109.2M. Top institutional holders of ANL by reported 13-F value include VR Adviser,, Cormorant Asset Management,, Squadron Capital Management, based on the most recent SEC filings. ANL trades on the Nasdaq exchange and files with the SEC under CIK 1944552. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ANL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Adlai Nortye Ltd. directly from SEC EDGAR.

Revenue

FY 2023

$5.0M

Net Income

FY 2023

$-109.2M

AI Insight: ANL Ratio Trends

Insufficient data: all key profitability and leverage metrics are unavailable for both reported periods.

No operating margin, net profit margin, ROE, ROA, ROIC, or D/E data is available for Q4 2023 or Q4 2024.

Disclosure of baseline profitability and leverage metrics is needed before any trend analysis can be conducted.

Get alerted when ANL's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Adlai Nortye Ltd. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Put ANL on your watchlist

Track score changes the day Adlai Nortye Ltd. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is ANL a good stock to buy?

13F Pro's AI-powered analysis of Adlai Nortye Ltd. (ANL) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ANL are available on the ANL stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own ANL?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ANL. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Adlai Nortye Ltd.'s investment landscape.